These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Rebalancing TGF-β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis. Yang Y, Sun M, Li W, Liu C, Jiang Z, Gu P, Li J, Wang W, You R, Ba Q, Li X, Wang H. Clin Transl Med; 2021 Jul 14; 11(7):e410. PubMed ID: 34323416 [Abstract] [Full Text] [Related]
13. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling. Wu SM, Li TH, Yun H, Ai HW, Zhang KH. Yonsei Med J; 2019 Jun 14; 60(6):561-569. PubMed ID: 31124340 [Abstract] [Full Text] [Related]
14. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Hyun J, Wang S, Kim J, Rao KM, Park SY, Chung I, Ha CS, Kim SW, Yun YH, Jung Y. Nat Commun; 2016 Mar 22; 7():10993. PubMed ID: 27001906 [Abstract] [Full Text] [Related]
15. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway. Tu X, Zhang H, Zhang J, Zhao S, Zheng X, Zhang Z, Zhu J, Chen J, Dong L, Zang Y, Zhang J. J Pathol; 2014 Sep 22; 234(1):46-59. PubMed ID: 24817606 [Abstract] [Full Text] [Related]
18. MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7. Ji F, Wang K, Zhang Y, Mao XL, Huang Q, Wang J, Ye L, Li Y. J Cell Biochem; 2019 Mar 22; 120(3):4573-4581. PubMed ID: 30368874 [Abstract] [Full Text] [Related]